MIT Technology Review · Nov 28, 2025
MIT Technology Review’s The Download surveys unknowns around weight-loss drugs and AI’s economy
Markdown · JSON · Original source
On November 28, 2025, MIT Technology Review’s The Download newsletter points to unresolved questions about weight-loss drugs and the economic effects of AI. It says reports raised questions about GLP-1 drugs, including whether they help people with Alzheimer’s disease and risks for people who stop taking them when pregnant. The newsletter says there is still a lot we do not know about these drugs. On AI’s economic effects, the newsletter asks whether the situation calls for pessimism, optimism, or a more nuanced view. It describes a planned subscriber conversation exploring what is happening across markets, not an answer already reached. A separate item says SWE-Bench, a test of AI models’ coding skill, has become popular, but entrants have begun to game it. The newsletter says a SWE-Bench score is not a truthful assessment of which model is “better,” raising the question of how to measure AI achievement. The economic effects of AI and the enduring questions about weight-loss drugs remain unresolved in this edition.
Headline and summary by Escape Meridian, prepared by Luna from the attributed source. A source check is not independent confirmation of the source’s claims.
Original source
MIT Technology Review · Article
Source details
Original source date: Nov 28, 2025 (2025-11-28T13:10:00Z).
Date basis: Date from the publisher’s own records, through its API.
Added to Escape Meridian: 2026-11-09T21:03:23.582Z. First observed: 2026-11-03T03:07:49.249Z. Retrieved: 2026-11-03T03:11:49.258Z.
Referenced by
Recorded citations and public file attachments. A reference alone does not establish agreement or influence.
No public references recorded here yet.
Limits
Text as retrieved on November 3, 2026; originally published November 28, 2025. The newsletter raises enduring questions about weight-loss drugs and AI’s economic effects but does not provide answers to them in this edition.
Open question
What evidence will clarify the economic effects of AI and the enduring questions about weight-loss drugs that this edition raises?
Source-stated
The newsletter says recent reports raised questions about GLP-1 drugs, including their effects for people with Alzheimer’s disease and risks associated with stopping them during pregnancy.
GLP-1 drugs don’t seem to help people with Alzheimer’s disease. And that people who stop taking the drugs when they become pregnant can experience potentially dangerous levels of weight gain.
Source-stated
The newsletter says uncertainty about weight-loss drugs remains substantial.
there’s a lot we still don’t know about these drugs.
Source-stated
The newsletter frames the economic effects of AI as an open question, asking whether the situation warrants optimism, pessimism, or a more nuanced view.
Should we be pessimistic? Optimistic? Or is the situation too nuanced for that?
Source-stated
The newsletter says SWE-Bench has become popular, while entrants have begun to game it, and argues that its score does not truthfully assess which model is better.
Despite all the fervor, this isn’t exactly a truthful assessment of which model is “better.” Entrants have begun to game the system
Source and contributor context
MIT Technology Review · Publisher
The publisher is identified here. No individual author has been inferred.
Source media
Media retrieval status: unchecked.
Terms and references
Reference context selected by Escape Meridian; separate from source evidence. Entity mentions do not establish authorship, involvement or endorsement.
Editorial provenance
Version 1. Publication ID: b9265ce2-c543-165d-5f1e-570abb49e09e.
Prepared by openai/gpt-6-luna; grounding review by anthropic/claude-opus-5.5.
Source check: uncertain by anthropic/claude-opus-5.5 on 2026-11-09T20:58:44.365Z. This checks fidelity to the source, not whether its claims are independently true.
Editorial selection: accept; reasons: bridge_admitted_by_model, second_opinion_categorical.
Observation: f9fb465834e25bc69d723ba280c4802369a19d1258115c3d6c4aec82149ca56c. Source text hash: 30aa4a649bbf32947fe2a29c612a5867483f148b30cef5cb38fcc5b4700b3311.
Revision and source-check history
Version 1 · 2026-11-09T21:03:23.582Z
MIT Technology Review’s The Download surveys unknowns around weight-loss drugs and AI’s economy
On November 28, 2025, MIT Technology Review’s The Download newsletter points to unresolved questions about weight-loss drugs and the economic effects of AI. It says reports raised questions about GLP-1 drugs, including whether they help people with Alzheimer’s disease and risks for people who stop taking them when pregnant. The newsletter says there is still a lot we do not know about these drugs. On AI’s economic effects, the newsletter asks whether the situation calls for pessimism, optimism, or a more nuanced view. It describes a planned subscriber conversation exploring what is happening across markets, not an answer already reached. A separate item says SWE-Bench, a test of AI models’ coding skill, has become popular, but entrants have begun to game it. The newsletter says a SWE-Bench score is not a truthful assessment of which model is “better,” raising the question of how to measure AI achievement. The economic effects of AI and the enduring questions about weight-loss drugs remain unresolved in this edition.
Original source
MIT Technology Review · Article
Source details
Original source date: Nov 28, 2025 (2025-11-28T13:10:00Z).
Date basis: Date from the publisher’s own records, through its API.
Added to Escape Meridian: 2026-11-09T21:03:23.582Z. First observed: 2026-11-03T03:07:49.249Z. Retrieved: 2026-11-03T03:11:49.258Z.
Limits
Text as retrieved on November 3, 2026; originally published November 28, 2025. The newsletter raises enduring questions about weight-loss drugs and AI’s economic effects but does not provide answers to them in this edition.
Open question
What evidence will clarify the economic effects of AI and the enduring questions about weight-loss drugs that this edition raises?
Source-stated
The newsletter says recent reports raised questions about GLP-1 drugs, including their effects for people with Alzheimer’s disease and risks associated with stopping them during pregnancy.
GLP-1 drugs don’t seem to help people with Alzheimer’s disease. And that people who stop taking the drugs when they become pregnant can experience potentially dangerous levels of weight gain.
Source-stated
The newsletter says uncertainty about weight-loss drugs remains substantial.
there’s a lot we still don’t know about these drugs.
Source-stated
The newsletter frames the economic effects of AI as an open question, asking whether the situation warrants optimism, pessimism, or a more nuanced view.
Should we be pessimistic? Optimistic? Or is the situation too nuanced for that?
Source-stated
The newsletter says SWE-Bench has become popular, while entrants have begun to game it, and argues that its score does not truthfully assess which model is better.
Despite all the fervor, this isn’t exactly a truthful assessment of which model is “better.” Entrants have begun to game the system
Source and contributor context
MIT Technology Review · Publisher
The publisher is identified here. No individual author has been inferred.
Source media
Media retrieval status: unchecked.
Terms and references
Reference context selected by Escape Meridian; separate from source evidence. Entity mentions do not establish authorship, involvement or endorsement.
Editorial provenance
Version 1. Publication ID: b9265ce2-c543-165d-5f1e-570abb49e09e.
Prepared by openai/gpt-6-luna; grounding review by anthropic/claude-opus-5.5.
Source check: uncertain by anthropic/claude-opus-5.5 on 2026-11-09T20:58:44.365Z. This checks fidelity to the source, not whether its claims are independently true.
Editorial selection: accept; reasons: bridge_admitted_by_model, second_opinion_categorical.
Observation: f9fb465834e25bc69d723ba280c4802369a19d1258115c3d6c4aec82149ca56c. Source text hash: 30aa4a649bbf32947fe2a29c612a5867483f148b30cef5cb38fcc5b4700b3311.
uncertain · 2026-11-09T20:58:44.365Z · anthropic/claude-opus-5.5
Publication: b9265ce2-c543-165d-5f1e-570abb49e09e
attribution — pass: The reading attributes the content to MIT Technology Review's The Download newsletter. This is one newsletter issue that comments on several items in its own words, not a bare index. Items are presented as the newsletter's statements rather than as established facts.
This is today's edition of The Download, our weekday newsletter
summary — pass: The reading accurately reflects the main threads: open questions about GLP-1 weight-loss drugs, an AI-economy roundtable framed as an open question rather than an answer, and the SWE-Bench item. A general reader can follow it because GLP-1 is framed as a weight-loss drug and SWE-Bench is glossed as a coding test. The question reflects the edition's open issues, though it is broad.
Should we be pessimistic? Optimistic? Or is the situation too nuanced for that?
date — pass: The originalPublished UTC day, November 28, 2025, matches the reading and the URL path. The kind is publisher-page, so no archive disclosure is required. The page includes later 'Deep Dive' related stories, such as OpenAI math findings, but the reading neither uses nor relies on them. The modifiedAt timestamp precedes publication, so no post-publication edit is indicated.
support — uncertain: The summary says the newsletter calls a SWE-Bench score 'not a truthful assessment', and claim 4 says the score 'does not truthfully assess' which model is better. The source hedges with 'isn't exactly', and its 'this' may refer to the leaderboard competition rather than the score alone. Dropping the hedge overstates the source's conviction. The smallest repair is to restore 'isn't exactly a truthful assessment'. The other claims are adequately supported.
Despite all the fervor, this isn’t exactly a truthful assessment of which model is “better.”
media — pass: No media is selected and no verified candidates were supplied, so nothing is misidentified.
Challenge or correct this reading
Send a correction or an opposing source with this reading’s URL. Disagreement and uncertainty can remain unresolved.